Mutation of MDM2 gene in Chinese Han women with idiopathic premature ovarian insufficiency.

OBJECTIVE Recent animal studies have demonstrated that the deletion of mouse double minute 2 (Mdm2) in mice leads to premature ovarian insufficiency (POI). The aim of the present study was to investigate whether mutations in the MDM2 gene contribute to POI in Chinese Han women. METHODS The coding region of the MDM2 gene was examined in 54 Chinese Han women with idiopathic POI and 54 Han healthy controls. Two known single nucleotide polymorphisms (SNPs), rs937283 in 5'-UTR and rs2870820 in intron 1, were compared between both POI and control groups. RESULTS There were no significant differences in the genotype distributions or allelic frequencies between the POI and control groups. No plausible causative mutations were identified. CONCLUSION Our findings suggest that mutations in the coding region of the MDM2 gene may not represent a risk factor in the pathogenesis of idiopathic POI among Chinese Han women. Although we fail to confirm that MDM2 is a disease-causing gene, our study is the first to investigate the role of MDM2 in POI patients. Further studies with larger sample size from different ethnic populations are warranted.

[1]  Y. Haupt,et al.  The role of MDM2 and MDM4 in breast cancer development and prevention , 2017, Journal of molecular cell biology.

[2]  Ying Zhou,et al.  Mouse Double Minute 2 Actively Suppresses p53 Activity in Oocytes during Mouse Folliculogenesis. , 2017, The American journal of pathology.

[3]  Huaiyang Jiang,et al.  MCM8 and MCM9 Nucleotide Variants in Women With Primary Ovarian Insufficiency , 2016, The Journal of clinical endocrinology and metabolism.

[4]  J. Marine,et al.  Loss of oocytes due to conditional ablation of Murine double minute 2 (Mdm2) gene is p53‐dependent and results in female sterility , 2016, FEBS letters.

[5]  U. Murty,et al.  Mutational analysis of the FIGLA gene in women with idiopathic premature ovarian failure , 2015, Menopause.

[6]  S. Berberich Mdm2 and MdmX involvement in human cancer. , 2014, Sub-cellular biochemistry.

[7]  B. Męczekalski,et al.  Genetics of premature ovarian failure. , 2010, Minerva endocrinologica.

[8]  Baoli Hu,et al.  Efficient p53 activation and apoptosis by simultaneous disruption of binding to MDM2 and MDMX. , 2007, Cancer research.

[9]  C. Sander,et al.  Gene expression profiling of liposarcoma identifies distinct biological types/subtypes and potential therapeutic targets in well-differentiated and dedifferentiated liposarcoma. , 2007, Cancer research.

[10]  L. Singh,et al.  Mutational screening of the coding region of growth differentiation factor 9 gene in Indian women with ovarian failure , 2005, Menopause.

[11]  N. Santoro Mechanisms of premature ovarian failure. , 2003, Annales d'endocrinologie.

[12]  J. Anasti,et al.  Premature ovarian failure: an update. , 1998, Fertility and sterility.